Predicted to enable alpha-tubulin binding activity. Acts upstream of or within cellular response to leukemia inhibitory factor. Predicted to be located in ciliary basal body. Predicted to be active in axoneme and mitotic spindle. Predicted to colocalize with microtubule. Orthologous to human EFHC2 (EF-hand domain containing 2). [provided by Alliance of Genome Resources, Apr 2022]